SpringWorks Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
SWTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Washington Boulevard, Stamford, CT

Insiders trading volume in the past year

SpringWorks Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephen P. Squinto Director, 10%+ Owner $262M May 19, 2022
Orbimed Advisors Llc 10%+ Owner $233M Sep 12, 2022
Bain Capital Life Sciences Investors, LLC 10%+ Owner $201M Aug 10, 2021
Jeffrey Schwartz Director $128M May 24, 2023
L. Mary Smith Chief Development Officer $9.69M Jan 4, 2024
Michael F. Burgess Head of Research & Development $2.06M Jul 18, 2022
Herschel S. Weinstein General Counsel & Secretary $0 Jul 1, 2025
Alan Fuhrman Director $0 Jul 1, 2025
Francis I. Perier Jr Chief Financial Officer $0 Jul 1, 2025
Freda Lewis-Hall Director $0 Jul 1, 2025
Daniel Pichl Chief People Officer $0 -$1.62M -100% Jul 1, 2025
Bhavesh Ashar Chief Commercial Officer $0 -$62.2K -100% Jul 1, 2025
James Cassidy Chief Medical Officer $0 Jul 1, 2025
Saqib Islam Chief Executive Officer, Director $0 -$9.65M -100% Jul 1, 2025
Martin Mackay Director $0 Jul 1, 2025
Badreddin Edris Chief Operating Officer $0 -$3.52M -100% Jul 1, 2025
Michael Nofi Chief Accounting Officer $0 Jul 1, 2025
Tai-An Lin Chief Scientific Officer $0 Jul 1, 2025
Carlos Alban Director $0 Jul 1, 2025
Julie Hambleton Director $0 -$730K -100% Jul 1, 2025
Daniel Lynch Director $0 -$12.4M -100% Jul 1, 2025

Recent Insider Transactions by Companies or Individuals for SpringWorks Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.